These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9294833)

  • 21. Effect of amphotericin B-deoxycholate (Fungizone) on the mitochondria of Wistar rats' renal proximal tubules cells.
    Alenazi SA; Elmorsy E; Al-Ghafari A; El-Husseini A
    J Appl Toxicol; 2021 Oct; 41(10):1620-1633. PubMed ID: 33740284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
    Alvarez C; Shin DH; Kwon GS
    Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effect of amphotericin B desoxycholate and amphotericin B colloidal dispersion on renal functions and renal morphology in rats.
    Doubek M; Mayer J; Lauschova I; Scheer P; Krejcirova L; Horky D; Doubek J
    Nephrology (Carlton); 2005 Feb; 10(1):57-62. PubMed ID: 15705183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
    Joly V; Dromer F; Barge J; Yeni P; Seta N; Molas G; Carbon C
    J Pharmacol Exp Ther; 1989 Oct; 251(1):311-6. PubMed ID: 2795463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments.
    Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
    J Antimicrob Chemother; 2005 May; 55(5):727-34. PubMed ID: 15761070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.
    Prentice HG; Hann IM; Herbrecht R; Aoun M; Kvaloy S; Catovsky D; Pinkerton CR; Schey SA; Jacobs F; Oakhill A; Stevens RF; Darbyshire PJ; Gibson BE
    Br J Haematol; 1997 Sep; 98(3):711-8. PubMed ID: 9332329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations.
    Andrew EC; Curtis N; Coghlan B; Cranswick N; Gwee A
    Br J Clin Pharmacol; 2018 May; 84(5):1006-1012. PubMed ID: 29352486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier.
    Usman F; Khalil R; Ul-Haq Z; Nakpheng T; Srichana T
    AAPS PharmSciTech; 2018 Jul; 19(5):2077-2086. PubMed ID: 29691753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amphotericin B and sodium deoxycholate induced impairment of renal p-aminohippurate accumulation (PAH) and effect on lipid peroxidation in the rat kidney.
    Inselmann G; Kutzschbach A; Heidemann HT
    Ren Fail; 1992; 14(1):17-21. PubMed ID: 1561385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute and chronic effects of flucytosine on amphotericin B nephrotoxicity in rats.
    Heidemann HT; Brune KH; Sabra R; Branch RA
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2670-5. PubMed ID: 1482135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphotericin B Loaded Nanostructured Lipid Carriers for Parenteral Delivery: Characterization, Antifungal and In vitro Toxicity Assessment.
    Nimtrakul P; Tiyaboonchai W; Lamlertthon S
    Curr Drug Deliv; 2019; 16(7):645-653. PubMed ID: 31362675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of renal toxicity and antifungal activity of free and liposomal amphotericin B following a single intravenous dose to diabetic rats with systemic candidiasis.
    Wasan KM; Conklin JS
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1806-10. PubMed ID: 8843285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations.
    Cannon JP; Garey KW; Danziger LH
    Pharmacotherapy; 2001 Sep; 21(9):1107-14. PubMed ID: 11560200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal handling of amphotericin B and amphotericin B-deoxycholate and potential renal drug-drug interactions with selected antivirals.
    Trejtnar F; Mandíková J; Kočíncová J; Volková M
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5650-7. PubMed ID: 24957831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Emulsion of amphotericin B in Intralipid 20%: in vitro and in vivo efficacy].
    Chavanet P; Charlier N; Brenet A; Goux A; Muggéo E; Caillot D; Casasnovas O; Kistermann JP; Waldner A; Portier H
    Pathol Biol (Paris); 1992 May; 40(5):507-12. PubMed ID: 1495835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B.
    Wasan KM; Rosenblum MG; Cheung L; Lopez-Berestein G
    Antimicrob Agents Chemother; 1994 Feb; 38(2):223-7. PubMed ID: 8192447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyene antibiotics: relative degrees of in vitro cytotoxicity and potential effects on tubule phospholipid and ceramide content.
    Zager RA
    Am J Kidney Dis; 2000 Aug; 36(2):238-49. PubMed ID: 10922301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties.
    Sawaya BP; Briggs JP; Schnermann J
    J Am Soc Nephrol; 1995 Aug; 6(2):154-64. PubMed ID: 7579079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo antifungal activity of amphotericin B lipid complex: are phospholipases important?
    Swenson CE; Perkins WR; Roberts P; Ahmad I; Stevens R; Stevens DA; Janoff AS
    Antimicrob Agents Chemother; 1998 Apr; 42(4):767-71. PubMed ID: 9559780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.